Viewing Study NCT04880395

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 1:41 PM
Ignite Modification Date: 2026-03-12 @ 2:50 PM
Study NCT ID: NCT04880395
Status: COMPLETED
Last Update Posted: 2025-07-30
First Post: 2021-04-26
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: Dolutegravir-Lamivudine for naïve HIV-Infected Patients With ≤200 CD4/mm3
Sponsor: Fundación Huésped
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None HIV-1-infection View
Keywords:

Keywords

Keyword Brief Keyword Text View
None antiretroviral naive triple therapy. Dolutegravir-Lamivudine View
None dual-therapy View